Fed. Circ. Pushed To Revive $200M Boston Scientific IP Suit
A California cardiologist claiming that Boston Scientific Corp. owes him more than $200 million in royalty payments for using his patented stent technology argued to a Federal Circuit panel Friday that...To view the full article, register now.
Already a subscriber? Click here to view full article